References
- American Cancer Society. Cancer statistics: 1985. CA 1985: 35(1): 19–35
- Stanley KE. Prognostic factors for survival in patients with inoperable lung cancer. JNCI 1980: 65(1): 25–32
- Minna JD, Higgins GA, Glatstein EJ. Cancer of the lung. In: DeVita VT Jr, Helman S. Rosenberg SA, eds. Cancer: principles and practice of oncology. 2ded. Philadelphia: JB Lippincott. 1985: 556–64
- Woods RL, Levi JA, Page J, et al. Non small cell cancer: a randomised comparison of chemotherapy with no chemotherapy. (Abstr C-691) Proc Am Soc Clin Oncol 1985: 4(Mar): 177
- Lad TE, Nelson RB, Diekamp U, et al. Immediate versus postponed combination chemotherapy (CAMP) for unresectable non—small cell lung cancer: a randomized trial. Cancer Treat Rep 1981: 65(11–12): 973–8
- Furnas BE, Williams SD, Einhorn LH, et al. Vindesine: an effective agent in the treatment of non—small cell lung cancer. Cancer Treat Rep 1982: 66(9): 1709–11
- Bakowski MT, Crouch JC. Chemotherapy of non—small cell lung cancer: a reappraisal and a look to the future. Cancer Treat Rev 1983: 10(3): 159–72
- Edmonson JH, Lagakos SW, Selawry OS, et al. Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung. Cancer Treat Rep 1976: 60(7): 925–32
- Einhorn LH, Williams SD, Stevens EE, et al. Random prospective study of cyclophosphamide, doxorubicin, and methotrexate (CAM) combination chemotherapy versus single-agent sequential chemotherapy in non small lung cancer. Cancer Treat Rep 1982: 66(12): 2005–11
- Livingston RB, Fee WH, Einhorn LH, et al. BACON (bleomycin, Adriamycin, CCNU, Oncovin and nitrogen mustard) in squamous lung cancer: experience in fifty patients. Cancer 1976: 37(3): 1237–42
- Livingston RB, Helibrun L, Lehane D, et al. Comparative trial of combination chemotherapy in extensive squamous carcinoma of the lung: a Southwest Oncology Group study. Cancer Treat Rep 1977: 61(9): 1623–9
- Miller TP, McMahon LJ, Livingston RB, et al. Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vincristine, and mitomycin C (FOMI). Cancer Treat Rep 1980: 64(12): 1241–5
- Miller TP, Chen TT, Coltman CA Jr, et al. Effect of alternating combination chemotherapy on survival of ambulatory patients with metastatic large-cell and adenocarcinoma of the lung: a Southwest Oncology Group study. J Clin Oncol 1986: 4(4): 502–8
- Eagan RT, Ingle JN, Frytak S, et al. Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non—small cell lung cancer. Cancer Treat Rep 1977: 61(7): 1330–45
- Krook JE, Fleming TR, Eagan RT, et al. Comparison of combination chemotherapy programs in advanced adenocarcinoma—large cell carcinoma of the lung: a North Central Cancer Treatment Group study. Cancer Treat Rep 1984: 68(3): 493–8
- Woodcock TM, Blumenreich MS, Richman SP, et al. Combination chemotherapy with cis-diamminedichloroplatinum and vinblastine in advanced non—small cell lung cancer. J Clin Oncol 1983: 1(4): 247–50
- Mason BA, Catalano RB. Mitomycin C/vinblastine/cisplatin combination chemotherapy in non—small cell lung cancer. Proc Am Soc Clin Oncol 1980: 21: 447
- Schulman P, Budman DR, Weiselberg L, et al. Phase II trial of mitomycin, vinblastine, and cisplatin (MVP) in non-small cell bronchogenic carcinoma. Cancer Treat Rep 1983: 67(10): 943–5
- Ruckdeschel JC, Finkelstein DM, Mason BA, et al. Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V—a randomized comparison of four cisplatin-containing regimens. J Clin Oncol 1985: 3(1): 72–9
- Ruckdeschel JC, Finkelstein DM, Ettinger DS, et al. A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer. J Clin Oncol 1986: 4(1): 14–22
- Gralla RJ, Casper ES, Kelaen DP, et al. Cisplatin and vindesine combination chemotherapy for advanced carcinoma of lung: a randomized trial investigating two dosage schedules. Ann Intern Med 1981: 95(4): 414–20